Tower Research Capital LLC (TRC) - THESEUS PHARMACEUTICALS INC ownership

THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 72 filers reported holding THESEUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of THESEUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$37,673
+144.2%
9,302
+62.2%
0.00%
Q3 2023$15,424
+136.8%
5,734
+721.5%
0.00%
Q2 2023$6,513
+50000.0%
698
-50.8%
0.00%
Q1 2023$13
-50.0%
1,418
-72.5%
0.00%
-100.0%
Q4 2022$26
-99.9%
5,150
+16.5%
0.00%
Q3 2022$26,000
+73.3%
4,420
+66.0%
0.00%
Q2 2022$15,000
-6.2%
2,663
+89.1%
0.00%
Q1 2022$16,000
-40.7%
1,408
-33.6%
0.00%
Q4 2021$27,0002,1200.00%
Other shareholders

There were no reported owners of THESEUS PHARMACEUTICALS INC in Q4 2023.

NameSharesValueWeighting ↓
View complete list of THESEUS PHARMACEUTICALS INC shareholders